FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323347912> ?p ?o ?g. }

• W4323347912 abstract "Individuals who are immunocompromised (IC) due to therapy or underlying disease are at increased risk of herpes zoster (HZ). This study evaluates the public health impact of recombinant zoster vaccine (RZV) relative to no HZ vaccination for the prevention of HZ among adults aged ≥18 years diagnosed with selected cancers in the United States (US). A static Markov model was used to simulate three cohorts of individuals who are IC with cancer (time horizon of 30 years; one-year cycle length): hematopoietic stem cell transplant (HSCT) recipients, patients with breast cancer (BC; a solid tumor example), and patients with Hodgkin's lymphoma (HL; a hematological malignancy example). Cohort sizes reflect the estimated annual incidence of each condition in the US population (19,671 HSCT recipients, 279,100 patients with BC, and 8,480 patients with HL). Vaccination with RZV resulted in 2,297; 38,068; and 848 fewer HZ cases for HSCT recipients, patients with BC, and patients with HL, respectively (each versus no vaccine). Vaccination with RZV also resulted in 422; 3,184; and 93 fewer postherpetic neuralgia cases for HSCT, BC, and HL, respectively. Analyses estimated the quality-adjusted life years gained to be 109, 506, and 17 for HSCT, BC, and HL, respectively. To prevent one HZ case, the number needed to vaccinate was 9, 8, and 10, for HSCT, BC, and HL, respectively. These results suggest RZV vaccination may be an effective option to significantly reduce HZ disease burden among patients diagnosed with selected cancers in the US.Shingles cases can be prevented by recombinant zoster vaccine (RZV). People who have a weakened immune system (immunocompromised) due to disease or therapy are more likely to develop shingles. For example, shingles occurs in nearly a quarter of patients receiving immunosuppressive treatment for blood cancers. To estimate the public health impact of vaccination against shingles in people who are immunocompromised due to cancer in the United States (US), we used a model to simulate groups with selected types of cancer. The results indicate vaccination with RZV can significantly reduce shingles cases and related complications among these groups in the US." @default.
• W4323347912 created "2023-03-08" @default.
• W4323347912 creator A5011564469 @default.
• W4323347912 creator A5012789388 @default.
• W4323347912 creator A5024437430 @default.
• W4323347912 creator A5026603950 @default.
• W4323347912 creator A5048233943 @default.
• W4323347912 creator A5057153239 @default.
• W4323347912 creator A5066680365 @default.
• W4323347912 creator A5084194739 @default.
• W4323347912 creator A5090910093 @default.
• W4323347912 date "2023-01-02" @default.
• W4323347912 modified "2023-10-10" @default.
• W4323347912 title "Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer" @default.
• W4323347912 cites W1012433823 @default.
• W4323347912 cites W2009736529 @default.
• W4323347912 cites W2010207831 @default.
• W4323347912 cites W2030756836 @default.
• W4323347912 cites W2086454732 @default.
• W4323347912 cites W2114213842 @default.
• W4323347912 cites W2171083512 @default.
• W4323347912 cites W2519957152 @default.
• W4323347912 cites W2563228496 @default.
• W4323347912 cites W2610190680 @default.
• W4323347912 cites W2615762503 @default.
• W4323347912 cites W2772112182 @default.
• W4323347912 cites W2784682748 @default.
• W4323347912 cites W2883596402 @default.
• W4323347912 cites W2903652021 @default.
• W4323347912 cites W2910284500 @default.
• W4323347912 cites W2912441127 @default.
• W4323347912 cites W2915317333 @default.
• W4323347912 cites W2924070172 @default.
• W4323347912 cites W2960588225 @default.
• W4323347912 cites W2965743944 @default.
• W4323347912 cites W2966872618 @default.
• W4323347912 cites W2984774302 @default.
• W4323347912 cites W2999417355 @default.
• W4323347912 cites W3163991358 @default.
• W4323347912 cites W3185631382 @default.
• W4323347912 cites W4206408785 @default.
• W4323347912 cites W4221038573 @default.
• W4323347912 cites W4304891453 @default.
• W4323347912 doi "https://doi.org/10.1080/21645515.2023.2167907" @default.
• W4323347912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36880669" @default.
• W4323347912 hasPublicationYear "2023" @default.
• W4323347912 type Work @default.
• W4323347912 citedByCount "1" @default.
• W4323347912 crossrefType "journal-article" @default.
• W4323347912 hasAuthorship W4323347912A5011564469 @default.
• W4323347912 hasAuthorship W4323347912A5012789388 @default.
• W4323347912 hasAuthorship W4323347912A5024437430 @default.
• W4323347912 hasAuthorship W4323347912A5026603950 @default.
• W4323347912 hasAuthorship W4323347912A5048233943 @default.
• W4323347912 hasAuthorship W4323347912A5057153239 @default.
• W4323347912 hasAuthorship W4323347912A5066680365 @default.
• W4323347912 hasAuthorship W4323347912A5084194739 @default.
• W4323347912 hasAuthorship W4323347912A5090910093 @default.
• W4323347912 hasBestOaLocation W43233479121 @default.
• W4323347912 hasConcept C120665830 @default.
• W4323347912 hasConcept C121332964 @default.
• W4323347912 hasConcept C121608353 @default.
• W4323347912 hasConcept C126322002 @default.
• W4323347912 hasConcept C142724271 @default.
• W4323347912 hasConcept C143998085 @default.
• W4323347912 hasConcept C187212893 @default.
• W4323347912 hasConcept C203014093 @default.
• W4323347912 hasConcept C204787440 @default.
• W4323347912 hasConcept C22070199 @default.
• W4323347912 hasConcept C2522874641 @default.
• W4323347912 hasConcept C2778866549 @default.
• W4323347912 hasConcept C2779001537 @default.
• W4323347912 hasConcept C2908647359 @default.
• W4323347912 hasConcept C61511704 @default.
• W4323347912 hasConcept C71924100 @default.
• W4323347912 hasConcept C99454951 @default.
• W4323347912 hasConceptScore W4323347912C120665830 @default.
• W4323347912 hasConceptScore W4323347912C121332964 @default.
• W4323347912 hasConceptScore W4323347912C121608353 @default.
• W4323347912 hasConceptScore W4323347912C126322002 @default.
• W4323347912 hasConceptScore W4323347912C142724271 @default.
• W4323347912 hasConceptScore W4323347912C143998085 @default.
• W4323347912 hasConceptScore W4323347912C187212893 @default.
• W4323347912 hasConceptScore W4323347912C203014093 @default.
• W4323347912 hasConceptScore W4323347912C204787440 @default.
• W4323347912 hasConceptScore W4323347912C22070199 @default.
• W4323347912 hasConceptScore W4323347912C2522874641 @default.
• W4323347912 hasConceptScore W4323347912C2778866549 @default.
• W4323347912 hasConceptScore W4323347912C2779001537 @default.
• W4323347912 hasConceptScore W4323347912C2908647359 @default.
• W4323347912 hasConceptScore W4323347912C61511704 @default.
• W4323347912 hasConceptScore W4323347912C71924100 @default.
• W4323347912 hasConceptScore W4323347912C99454951 @default.
• W4323347912 hasIssue "1" @default.
• W4323347912 hasLocation W43233479121 @default.
• W4323347912 hasLocation W43233479122 @default.
• W4323347912 hasLocation W43233479123 @default.
• W4323347912 hasLocation W43233479124 @default.
• W4323347912 hasOpenAccess W4323347912 @default.
• W4323347912 hasPrimaryLocation W43233479121 @default.

• next